Phathom Pharmaceuticals Inc (PHAT)
7.36
-0.09
(-1.21%)
USD |
NASDAQ |
Dec 23, 14:59
Phathom Pharmaceuticals Free Cash Flow: -247.72M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Merck & Co Inc | 14.84B |
| Galectin Therapeutics Inc | -33.68M |
| AbbVie Inc | 15.62B |
| Poseida Therapeutics Inc | -17.13M |
| Janux Therapeutics Inc | -37.82M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -63.57M |
| Cash from Investing (Quarterly) | -0.044M |
| Cash from Financing (Quarterly) | 122.06M |
| Free Cash Flow Per Share (Quarterly) | -0.9844 |
| Free Cash Flow to Equity (Quarterly) | -64.92M |
| Free Cash Flow Yield | -56.35% |